JP2011130862A - Medical double-chamber container - Google Patents

Medical double-chamber container Download PDF

Info

Publication number
JP2011130862A
JP2011130862A JP2009291592A JP2009291592A JP2011130862A JP 2011130862 A JP2011130862 A JP 2011130862A JP 2009291592 A JP2009291592 A JP 2009291592A JP 2009291592 A JP2009291592 A JP 2009291592A JP 2011130862 A JP2011130862 A JP 2011130862A
Authority
JP
Japan
Prior art keywords
port
chamber
indicator
released
container
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009291592A
Other languages
Japanese (ja)
Other versions
JP5728806B2 (en
Inventor
Minoru Honda
稔 本田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nipro Corp
Original Assignee
Nipro Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nipro Corp filed Critical Nipro Corp
Priority to JP2009291592A priority Critical patent/JP5728806B2/en
Publication of JP2011130862A publication Critical patent/JP2011130862A/en
Application granted granted Critical
Publication of JP5728806B2 publication Critical patent/JP5728806B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a medical double-chamber container having an unopened administration preventing mechanism capable of confirming that the inside of the whole container is opened without generating a liquid pool within the medical solution container. <P>SOLUTION: The medical double-chamber container filled with a medicine includes: a plurality of storage chambers enclosing the medicine, at least one of which encloses the medicine; a partition tool for dividing the container into the respective storage chambers to be opened by pressing; a port disposed in either one of the storage chambers; an inhibition disposed within the port for inhibiting the medicine from being discharged to an outlet without liquid-tightly separating the storage chamber with the port from the outlet to be released by the liquid pressure generated from the pressing when the storage chamber is opened; and an indicator set around the port for recognizing whether the inhibition is released or not. The indicator is the last to be released among the partition tool, the inhibition and the indicator. <P>COPYRIGHT: (C)2011,JPO&INPIT

Description

本発明は、医療用複室容器に関する。より詳しくは、薬液が調製されないまま人体へ投与されることを防ぐ医療用複室容器である。   The present invention relates to a medical multi-chamber container. More specifically, the medical multi-chamber container prevents the drug solution from being administered to the human body without being prepared.

予め混合した状態で保管しておくと変質などによって保存性が悪くなる薬剤や薬液がある。これらの薬剤や薬液は個別に保管され、使用直前に無菌混合によって混合され使用される。保管時には薬剤や薬液を個々に保管し、使用時にはこれらの薬剤や薬液を無菌混合するために医療用複室容器が用いられている。   There are drugs and chemicals that have poor storability due to alteration when stored in a premixed state. These drugs and drug solutions are stored separately and mixed and used by aseptic mixing immediately before use. A medical multi-chamber container is used for storing drugs and drug solutions individually during storage and for aseptic mixing of these drugs and drug solutions during use.

これは、容易に剥離可能な弱シール部によって区画される複数の室内に複数の薬剤及び薬液を別々に保存しておき、薬剤投与の直前に容器を手で押圧するなどして弱シール部を剥離させ、複数の室を連通させて内容物を無菌状態で混合あるいは溶解させるというものである。   This is because a plurality of medicines and chemical solutions are stored separately in a plurality of chambers partitioned by weak seal parts that can be easily peeled off, and the weak seal parts are removed by pressing the container by hand immediately before drug administration. The contents are exfoliated and the contents are mixed or dissolved under aseptic conditions by communicating with a plurality of chambers.

このような医療用複室容器は、別々に保存した薬剤を開通するまで無菌的に安定した状態で保管できる一方で、開通を失念し、調製された薬剤ではなく、ポート側の薬剤のみを投与してしまう可能性がある。   Such a medical multi-chamber container can be stored in a sterile and stable state until a separately stored drug is opened, but forgets to open and only the drug on the port side is administered, not the prepared drug. There is a possibility that.

未連通状態での患者への複室容器からの薬剤投与を回避するために、未連通状態で薬剤を投与しないような機構が提案されている。特開平9−327498号や特開2005−288022号に開示されているものは、薬剤室とポートとの間に弱シールにて区画された空室を設けることによって、連通するまでポートへ薬剤が流通せず、薬剤が投与できない構造となっており、連通操作を行うことによって、当該弱シールが剥離し薬剤がポートへ流入することによって薬剤が投与可能となる構造である。   In order to avoid administration of a drug from a multi-chamber container to a patient in an unconnected state, a mechanism has been proposed in which the drug is not administered in an unconnected state. JP-A-9-327498 and JP-A-2005-288022 provide a vacant chamber partitioned by a weak seal between a drug chamber and a port, so that a drug is allowed to reach the port until communication is established. It is a structure that does not circulate and cannot administer the drug. By performing a communication operation, the weak seal is peeled off and the drug flows into the port so that the drug can be administered.

しかしながら、上記の構造では、ポート内に水分が存在しないため、ポート内の滅菌が保証されず、滅菌するためには薬剤室とポートとの間に、水分を別途入れる等して滅菌を行うため製造が煩雑となる。滅菌の問題を解決するために、上記の発展系として、弱シールにて蒸気のみ通過可能な隙間を設けて区画された空室を設けるものが提案されている(特許文献1)。   However, in the above structure, since there is no moisture in the port, sterilization in the port is not guaranteed, and in order to sterilize, sterilization is performed by separately inserting moisture between the drug chamber and the port. Manufacturing becomes complicated. In order to solve the problem of sterilization, as the above-mentioned development system, there has been proposed a system in which a vacant space partitioned by providing only a vapor through a weak seal is provided (Patent Document 1).

他の未連通状態で薬剤を投与しないような機構については、ポート内に、薬剤室とポートとを区画する、液密に摺動可能な栓を備えており、当該栓は、液圧を受けて下方に摺動する構造となっており、未連通の状態ではポートに薬液が流通しない状態となっており、連通操作を行うと、栓が摺動してポートと薬剤室とを連通する連通路が出現し、投与可能となる構造が提案されている(特許文献2)。   For other mechanisms that do not administer the drug in an unconnected state, the port is provided with a liquid-tight slidable plug that separates the drug chamber from the port. When the communication operation is performed, the stopper slides and the port and the drug chamber communicate with each other. A structure in which a passage appears and can be administered has been proposed (Patent Document 2).

特開2006−507914号JP 2006-507914 A 特開2003−28036号JP 2003-28036 A

しかしながら、特許文献1については、未連通状態での投与防止のための構造として弱シール部が容器下部に存在するため、弱シール部が完全に剥離しなかった時、特に、複室容器周面と接する弱シール部分がうまく剥離しなかった時には、複室容器周面と弱シール部との間に液が溜まり、複室容器内の薬液の排出がされにくくなる可能性がある。また、空室及びポート内に水分はなく、蒸気のみ通過可能となっているので、蒸気滅菌のさいに、空室の気体と薬剤室内で発生した蒸気とが、滅菌に必要な量の交換が行われない可能性がある。   However, with respect to Patent Document 1, since the weak seal portion exists in the lower part of the container as a structure for preventing administration in a non-communication state, particularly when the weak seal portion does not completely peel, When the weak seal portion in contact with the gas does not peel off well, liquid may accumulate between the peripheral surface of the multi-chamber container and the weak seal portion, and it may be difficult to discharge the chemical solution in the multi-chamber container. In addition, since there is no moisture in the vacant chamber and the port and only steam can pass through, the amount of gas necessary for sterilization can be exchanged between the gas in the vacant chamber and the vapor generated in the drug chamber during steam sterilization. May not be done.

特許文献2のように、ポート内に未連通状態での投与防止対策の部材(栓)を設けると、連通操作と連動して栓がポート内で摺動したか(投与防止状態が解除されたか)どうかを視認する方法がなく、連通されても投与防止状態が解除されていない場合があっても、排出口に投与ラインを接続するまで確認することができない。また、ポート内部で、連通操作の際に栓が誤作動を生じても確認することができない。   When a member (plug) for preventing administration in a non-communication state is provided in the port as in Patent Document 2, whether the stopper slides in the port in conjunction with the communication operation (whether the administration prevention state has been released) ) There is no way to visually check whether or not the administration prevention state is not released even if connected, but it cannot be confirmed until the administration line is connected to the discharge port. Moreover, even if the stopper malfunctions during the communication operation inside the port, it cannot be confirmed.

そこで、薬液容器及びポート内の全体を滅菌することが可能であり、薬液容器内の薬剤の導出が円滑にできるとともに、未連通投与防止機構については容器内全てが連通したことが視認可能な構造が必要である。   Therefore, it is possible to sterilize the whole of the chemical solution container and the port, it is possible to smoothly lead out the drug in the chemical solution container, and it is possible to visually recognize that the inside of the container is in communication about the non-communication administration prevention mechanism is required.

本発明の目的は、薬液容器内に液溜まりが生じず、容器内全てが連通したことを確認可能な未連通投与防止機構を有する医療用複室容器を提供することにある。   An object of the present invention is to provide a medical multi-chamber container having a non-communication administration preventing mechanism capable of confirming that all of the inside of the container is in communication without causing a liquid pool in the chemical container.

そこで、本発明者等は、薬剤入りの医療用複室容器であって、なくとも一つの室に薬液が封入された、薬剤が封入された複数の収容室と、前記各収容室を仕切る、押圧により開通可能な仕切り手段と、前記いずれか一方の収容室に設けられた、収容室に収容された薬剤を排出するため排出口を有するポートと、前記ポート内に設けられた、ポートが設けられた収容室と排出口とを液密に区画することなく排出口への薬剤の排出を阻害し、かつ収容室開通時の押圧によって生じる液圧によって解除される阻害手段と、前記阻害手段が解除されたかどうかが分かるようにポート周辺に設けられたインジケーターとを備え、前記仕切り手段と、前記阻害手段と、前記インジケーターのうち、前記インジケーターが最後に解除されることを特徴とする医療用複室容器、を用いることにより、液溜まりが生じず、薬液容器内の連通が完了したことが視認できることを見出し、本願発明に至った。   Therefore, the present inventors are medical multi-chamber containers containing a medicine, in which a chemical solution is sealed in at least one chamber, a plurality of storage chambers in which a medicine is sealed, and each of the storage chambers, There are provided partition means that can be opened by pressing, a port provided in one of the storage chambers and having a discharge port for discharging the medicine stored in the storage chamber, and a port provided in the port. A blocking means that inhibits discharge of the medicine to the discharge port without partitioning the storage chamber and the discharge port formed in a liquid-tight manner, and is released by a hydraulic pressure generated by a pressure when the storage chamber is opened; and An indicator provided around the port so that it can be determined whether the indicator has been released, the partitioning unit, the inhibiting unit, and the indicator being released last. Ryoyo multiple chambers, by using not occur sump, it found that visible be communicated in the drug solution container is completed, leading to the present invention.

前記仕切り手段と、前記阻害手段と、前記インジケーターは、前記仕切り手段が最初に解除され、前記インジケーターが前記阻害手段と略同時に解除される構成としてもよい。   The partition unit, the inhibition unit, and the indicator may be configured such that the partition unit is first released and the indicator is released substantially simultaneously with the inhibition unit.

前記インジケーターは、前記ポートが設けられた収容室の、室の縁に接しないように形成された、収容室の一部を弱シールしたものでもよい。   The indicator may be one in which a part of the storage chamber formed so as not to contact the edge of the storage chamber provided with the port is weakly sealed.

前記仕切り手段と前記阻害手段と前記インジケーターとを解除する容器の内圧の関係が、阻害手段<仕切り手段<インジケーターとなることが好ましい。   It is preferable that the relationship between the internal pressures of the containers for releasing the partitioning means, the inhibiting means, and the indicator is inhibition means <partitioning means <indicator.

前記阻害手段は、ポート内壁に設けられた弾性体の枠体と枠体に液密に装着されたプラスチック部材で構成されていてもよい。   The inhibiting means may be composed of an elastic frame provided on the inner wall of the port and a plastic member that is liquid-tightly attached to the frame.

前記プラスチック部材には、軸基準断面積が0.03〜0.8mm以下の孔を有することが好ましい。 Wherein the plastic member, the axis reference sectional area preferably has a 0.03~0.8Mm 2 following hole.

本発明の医療用複室容器は、微量の液をポートに存在させることができるため、滅菌が簡単であり、ポート内に未連通投与防止機構を備えるため、収容室中に液溜まりを生じず、かつ、視認できる位置にインジケーターを設けることによって、ポート内の未連通投与防止機構が解除されたかどうかを確認可能であるため、医療に好適に用いることができる。   Since the medical multi-chamber container of the present invention allows a small amount of liquid to be present in the port, sterilization is simple, and since the non-communication administration preventing mechanism is provided in the port, no liquid pool is generated in the storage chamber. In addition, by providing an indicator at a visually recognizable position, it is possible to confirm whether or not the uncommunication administration preventing mechanism in the port has been released, so that it can be suitably used for medical treatment.

本発明の医療用複室容器の一実施態様例の縦断面図である。It is a longitudinal cross-sectional view of one embodiment of the medical multi-chamber container of the present invention. 図1の医療用複室容器のポート部分の部分拡大縦断面図である。It is the elements on larger scale of the port part of the medical multi-chamber container of FIG.

以下、図を用いて本発明の医療用複室容器を説明する。しかし、本願発明は、これら図面に記載した実施態様例に限定されるものではない。   Hereinafter, the medical multi-chamber container of the present invention will be described with reference to the drawings. However, the present invention is not limited to the exemplary embodiments described in these drawings.

図1は、本発明の医療用複室容器の一実施態様例の縦断面図である。図2は、図1の医療用複室容器のポート部分の部分拡大縦断面図である。   FIG. 1 is a longitudinal sectional view of an embodiment of the medical multi-chamber container of the present invention. 2 is a partially enlarged longitudinal sectional view of a port portion of the medical multi-chamber container of FIG.

本発明の医療用複室容器について、図1及び図2を例として説明する。容器本体1を上下に分割するように仕切り手段2である弱シール部が設けられ、弱シール部によって上部室3及び下部室4が形成されている、容器本体1の上部には、吊り下げ穴5が形成され、下部には、下部室と連通するように設けられた、下端に注出口61が設けられたポート6を有する。注出口はゴム栓62によって密封されている。ポート内部には、弾性体の枠体63が設けられており、弾性体の枠体63に、阻害手段64であるプラスチック部材が嵌合している。プラスチック部材が嵌合した枠体63によって、ポート内の注出口側と容器本体とは遮断されている。プラスチック部材には、微量の液が通過可能なように微孔65が開口している。枠体の下方には、脱落後の阻害手段がポートのゴム栓が備えられている部分まで落下しないよう阻害手段受け66が備えられている。下部室の領域内の下方には、下部室の面を弱シール溶着したインジケーター7が設けられている。   The medical multi-chamber container of the present invention will be described with reference to FIGS. A weak seal portion as partition means 2 is provided so as to divide the container main body 1 into upper and lower parts, and an upper chamber 3 and a lower chamber 4 are formed by the weak seal portion. 5 is formed, and a port 6 provided with a spout 61 at the lower end is provided in the lower part so as to communicate with the lower chamber. The spout is sealed with a rubber stopper 62. An elastic frame 63 is provided inside the port, and a plastic member as the inhibiting means 64 is fitted into the elastic frame 63. The spout side in the port and the container body are shut off by the frame 63 fitted with the plastic member. The plastic member has a micro-hole 65 that allows a small amount of liquid to pass therethrough. Below the frame, an inhibition means receiver 66 is provided so that the inhibition means after dropping does not fall to the portion where the rubber plug of the port is provided. Below the lower chamber region, an indicator 7 having a weak seal welded to the surface of the lower chamber is provided.

薬液の収容されている室を外側より押圧して連通操作を行うと、仕切り手段2及びインジケーター7が剥離し、かつプラスチック部材64が弾性体の枠体より脱落し、連通が完了する。この時、インジケーター7が最後に剥離するようになっており、インジケーター7の剥離をもって、複室容器内全体が連通したことが視認できるようになっている。   When the communication operation is performed by pressing the chamber containing the chemical solution from the outside, the partitioning means 2 and the indicator 7 are peeled off, and the plastic member 64 is detached from the elastic frame, and the communication is completed. At this time, the indicator 7 is peeled off last, and it is possible to visually recognize that the entire inside of the multi-chamber container is in communication with the peeling of the indicator 7.

なお、インジケーターが解除されることによって連通したことを視認可能であればよいため、前記仕切り手段と、前記阻害手段と、前記インジケーターの関係は、前記仕切り手段が最初に解除され、前記インジケーターが前記阻害手段と略同時に解除されるようにしてもよい。   In addition, since it is only necessary to visually recognize that the communication has been established by releasing the indicator, the relationship between the partition unit, the inhibition unit, and the indicator is such that the partition unit is first released and the indicator is You may make it cancel | release substantially simultaneously with the inhibition means.

プラスチック部材には、微量の液が通過可能なように微孔65が開口しているため、ポートの注出口側は完全に密閉されておらず、ポートの注出口側には微量の液体が侵入可能である。そのため、ポートの注出口側に侵入した微量の液体によって、高圧蒸気滅菌によって複室容器内全体の無菌性が担保できる。微孔65は、液体がポートに侵入する量を考慮すると、軸基準断面積が0.03〜0.8mmの孔であることが好ましい。 The plastic member has micro-holes 65 that allow a small amount of liquid to pass through, so the port outlet side is not completely sealed, and a small amount of liquid enters the port outlet side. Is possible. Therefore, the sterility of the entire multi-chamber container can be secured by high-pressure steam sterilization with a small amount of liquid entering the outlet side of the port. The micropore 65 is preferably a hole having an axial reference cross-sectional area of 0.03 to 0.8 mm 2 in consideration of the amount of liquid entering the port.

薬剤室の材質は、薬剤が安定的に保存可能であれば材質は特に限定されるものではなく、通常、薬剤バッグに用いられる合成樹脂製フィルムで形成される。薬剤が粉末である場合には、薬剤を安定に保存可能であって、ガス・水分遮断性を有し、バッグ強度に優れるものが好ましく、フィルムを袋状にしたときに薬剤と接する最内層が薬剤を安定的に保存可能であるポリエチレン及び環状ポリオレフィン、中間層が水分及びガスを遮断にし,印刷強度に優れる蒸着ポリエチレンテレフタレート、外界側となる最外層が製袋性に優れたポリエチレン又はポリエチレンテレフタレートで形成される積層フィルムを用いることが特に好ましい。このようにフィルムを積層することによって、合成樹脂を透過しようとする水分やガスを遮断することが可能である。また、薬剤が液体である場合には、低温衝撃に強く柔軟性に優れるポリエチレンを用いることが好ましい。   The material of the drug chamber is not particularly limited as long as the drug can be stably stored, and is usually formed of a synthetic resin film used for a drug bag. When the drug is a powder, it is preferable that the drug can be stably stored, has gas / moisture barrier properties, and has excellent bag strength, and has an innermost layer that comes into contact with the drug when the film is formed into a bag shape. Polyethylene and cyclic polyolefin that can stably store chemicals, vapor-deposited polyethylene terephthalate with an intermediate layer that blocks moisture and gas, and excellent printing strength, and the outermost layer on the outside is polyethylene or polyethylene terephthalate with excellent bag-making properties. It is particularly preferable to use a laminated film to be formed. By laminating films in this way, it is possible to block moisture and gas that are going to permeate the synthetic resin. When the drug is a liquid, it is preferable to use polyethylene that is resistant to low temperature impact and excellent in flexibility.

容器本体1は、上部室及び下部室に封入する薬剤が同じ素材の積層フィルムが適している場合には、容器本体を一体成型で形成し、複室となるように弱シール部で区画してもよい。しかし、容器本体の構造は上記図1のみに限定されるものではなく、薬剤保存に適したフィルムの積層素材を換える必要がある場合、第一の薬剤室と第二の薬剤室とを別々に製造して連結させて容器本体としてもよい。また、フロントシートとリアシートとに分割して形成したフィルムを貼り合わせてもよい。   When the container body 1 is a laminated film made of the same material as the medicine sealed in the upper chamber and the lower chamber, the container body 1 is formed by integral molding and is divided by a weak seal portion so as to be a multiple chamber. Also good. However, the structure of the container body is not limited to FIG. 1 described above. When it is necessary to change the laminated material of the film suitable for drug storage, the first drug chamber and the second drug chamber are separately provided. It is good also as a container main body by manufacturing and connecting. A film formed by dividing the front seat and the rear seat may be bonded together.

弱シール部は、各々の薬剤室が液体密に区画可能であって、容器を押圧した際には速やかに各々の薬剤室が連通可能であれば、構造は特に問わない。例えば、最内層がポリエチレンとポリプロピレンとのポリマーブレンドである場合には、容器本体を200〜250℃で溶着し、弱シール部形成用シートを120℃前後で溶着して弱シール部を形成することによって、連通時の押圧によって容器周縁は剥離することなく弱シール部のみを剥離可能とする構造を達成することができる。また、弱シール部に弱シール部形成用シートを咬ませて弱シール部を形成する場合、このシートは通常、最内層の材料と溶着強度の弱い樹脂が採用される。例えば、最内層がポリエチレンである場合、ポリエチレンとポリプロピレンとを3:7〜7:3に混合したポリマーブレンドが好適に採用される。最内層の材料と溶着強度の弱い樹脂を用いることによって、最内層と溶着しない箇所が弱シール部に点在するため弱シールが可能となる。   The structure of the weak seal portion is not particularly limited as long as each drug chamber can be partitioned in a liquid-tight manner and each drug chamber can be quickly communicated when the container is pressed. For example, when the innermost layer is a polymer blend of polyethylene and polypropylene, the container body is welded at 200 to 250 ° C., and the weak seal portion forming sheet is welded at around 120 ° C. to form the weak seal portion. Thus, it is possible to achieve a structure in which only the weak seal portion can be peeled without peeling off the peripheral edge of the container due to pressing during communication. When the weak seal portion forming sheet is bitten into the weak seal portion to form the weak seal portion, the innermost layer material and the resin having low welding strength are usually used for the sheet. For example, when the innermost layer is polyethylene, a polymer blend in which polyethylene and polypropylene are mixed at 3: 7 to 7: 3 is suitably employed. By using the resin of the innermost layer and the resin having a weak welding strength, weak seals are possible because the portions not welded to the innermost layer are scattered in the weak seal portion.

ポート6は筒状体であって、ポート下部の注出口には栓体が装着されている。栓体のゴムには通常、イソプレンゴム、ブタジエンゴム等が用いられる。   The port 6 is a cylindrical body, and a plug is attached to the spout at the bottom of the port. Usually, isoprene rubber, butadiene rubber or the like is used as the rubber of the plug.

仕切り手段2、阻害手段65、及びインジケーター7のうち、インジケーター7が最後に剥離するか、仕切り手段2が最初に剥離し、インジケーターが阻害手段と略同時に剥離する構成とすればよい。インジケーターの剥離をもって、複室容器内全てが連通したことが視認可能となる。よって、ポート内部が見えなくとも、インジケーターが剥離するまで容器本体を外部より押圧し続ければ阻害手段は解除されていることが確認できる。   Of the partition unit 2, the inhibition unit 65, and the indicator 7, the indicator 7 may be peeled last, or the partition unit 2 may be peeled first, and the indicator may be peeled off almost simultaneously with the inhibition unit. With the peeling of the indicator, it becomes visible that all the inside of the multi-chamber container communicated. Therefore, even if the inside of the port is not visible, it can be confirmed that the blocking means is released if the container body is continuously pressed from the outside until the indicator peels.

本発明の医療用複室容器は、上述のように、微量の液をポートに存在させることができるため、滅菌が簡単であり、ポート内に未連通投与防止機構を備えるため、収容室中に液溜まりを生じず、かつ、視認できる位置にインジケーターを設けることによって、ポート内の未連通投与防止機構が解除されたかどうかを確認可能であるため、医療に好適に用いることができる。   Since the medical multi-chamber container of the present invention allows a small amount of liquid to be present in the port as described above, it is easy to sterilize and includes a non-communication administration preventing mechanism in the port. Since it is possible to confirm whether or not the non-communication administration preventing mechanism in the port has been released by providing an indicator at a position where liquid accumulation does not occur and is visible, it can be suitably used for medical treatment.

1 容器本体
2 仕切り手段
3 上部室
4 下部室
5 吊り下げ穴
6 ポート
61 注出口
62 ゴム栓
63 枠体
64 阻害手段
65 微孔
66 阻害手段受け
7 インジケーター
DESCRIPTION OF SYMBOLS 1 Container body 2 Partitioning means 3 Upper chamber 4 Lower chamber 5 Hanging hole 6 Port 61 Outlet 62 Rubber stopper 63 Frame body 64 Inhibiting means 65 Micro hole 66 Inhibiting means receptacle 7 Indicator

Claims (6)

薬剤入りの医療用複室容器であって、
少なくとも一つの室に薬液が封入された、薬剤が封入された複数の収容室と、
前記各収容室を仕切る、押圧により開通可能な仕切り手段と、
前記いずれか一方の収容室に設けられた、収容室に収容された薬剤を排出するため排出口を有するポートと、
前記ポート内に設けられた、ポートが設けられた収容室と排出口とを液密に区画することなく排出口への薬剤の排出を阻害し、かつ収容室開通時の押圧によって生じる液圧によって解除される阻害手段と、
前記阻害手段が解除されたかどうかが分かるようにポート周辺に設けられたインジケーターと
を備え、
前記仕切り手段と、前記阻害手段と、前記インジケーターのうち、前記インジケーターが最後に解除されることを特徴とする医療用複室容器。
A medical multi-chamber container containing a medicine,
A plurality of storage chambers in which a drug solution is sealed, in which a drug solution is sealed in at least one chamber;
Partitioning means for partitioning each of the storage chambers, which can be opened by pressing;
A port provided in any one of the storage chambers and having a discharge port for discharging the drug stored in the storage chamber;
Due to the hydraulic pressure generated in the port, which inhibits the discharge of the medicine to the discharge port without liquid-tightly dividing the storage chamber provided with the port and the discharge port, and is generated by pressing when the storage chamber is opened Inhibition means to be released,
An indicator provided around the port so that it can be seen whether the inhibition means has been released,
The medical multi-chamber container, wherein the indicator is finally released among the partitioning unit, the inhibiting unit, and the indicator.
薬剤入りの医療用複室容器であって、
少なくとも一つの室に薬液が封入された、薬剤が封入された複数の収容室と、
前記各収容室を仕切る、押圧により開通可能な仕切り手段と、
前記いずれか一方の収容室に設けられた、収容室に収容された薬剤を排出するため排出口を有するポートと、
前記ポート内に設けられた、ポートが設けられた収容室と排出口とを液密に区画することなく排出口への薬剤の排出を阻害し、かつ収容室開通時の押圧によって生じる液圧によって解除される阻害手段と、
前記阻害手段が解除されたかどうかが分かるようにポート周辺に設けられたインジケーターと
を備え、
前記仕切り手段と、前記阻害手段と、前記インジケーターのうち、前記仕切り手段が最初に解除され、
前記インジケーターが前記阻害手段と略同時に解除されることを特徴とする医療用複室容器。
A medical multi-chamber container containing a medicine,
A plurality of storage chambers in which a drug solution is sealed, in which a drug solution is sealed in at least one chamber;
Partitioning means for partitioning each of the storage chambers, which can be opened by pressing;
A port provided in any one of the storage chambers and having a discharge port for discharging the drug stored in the storage chamber;
Due to the hydraulic pressure generated in the port, which inhibits the discharge of the medicine to the discharge port without liquid-tightly dividing the storage chamber provided with the port and the discharge port, and is generated by pressing when the storage chamber is opened Inhibition means to be released,
An indicator provided around the port so that it can be seen whether the inhibition means has been released,
Of the partitioning means, the inhibiting means, and the indicator, the partitioning means is first released,
The medical multi-chamber container, wherein the indicator is released substantially simultaneously with the inhibiting means.
前記インジケーターは、前記ポートが設けられた収容室の、室の縁に接しないように形成された、収容室の一部を弱シールしたものである、請求項1または2に記載の医療用複室容器。   The medical indicator according to claim 1 or 2, wherein the indicator is a part of the accommodation chamber formed so as not to contact an edge of the accommodation chamber provided with the port and is weakly sealed. Chamber container. 前記仕切り手段と前記阻害手段と前記インジケーターとを解除する容器の内圧の関係が、阻害手段<仕切り手段<インジケーターとなることを特徴とする請求項3記載の医療用複室容器。   4. The medical multi-chamber container according to claim 3, wherein the relationship between the internal pressures of the containers for releasing the partitioning means, the inhibiting means, and the indicator is inhibition means <partitioning means <indicator. 前記阻害手段は、ポート内壁に設けられた弾性体の枠体と枠体に液密に装着されたプラスチック部材で構成されてなる、請求項1〜4のいずれかに記載の医療用複室容器。   The medical multi-chamber container according to any one of claims 1 to 4, wherein the inhibiting means is composed of an elastic frame provided on an inner wall of the port and a plastic member that is liquid-tightly attached to the frame. . 前記プラスチック部材には、軸基準断面積が0.03〜0.8mmの孔を有することを特徴とする、請求項1〜5のいずれかに記載の医療用複室容器。 Wherein the plastic member, the axis reference cross-sectional area and having a hole of 0.03~0.8Mm 2, multi-chamber medical container according to claim 1.
JP2009291592A 2009-12-23 2009-12-23 Medical multi-chamber container Active JP5728806B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009291592A JP5728806B2 (en) 2009-12-23 2009-12-23 Medical multi-chamber container

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2009291592A JP5728806B2 (en) 2009-12-23 2009-12-23 Medical multi-chamber container

Publications (2)

Publication Number Publication Date
JP2011130862A true JP2011130862A (en) 2011-07-07
JP5728806B2 JP5728806B2 (en) 2015-06-03

Family

ID=44344245

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009291592A Active JP5728806B2 (en) 2009-12-23 2009-12-23 Medical multi-chamber container

Country Status (1)

Country Link
JP (1) JP5728806B2 (en)

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005059853A (en) * 2003-08-11 2005-03-10 Shimizu Pharmaceutical Co Ltd Plastic container
JP2006187558A (en) * 2005-01-07 2006-07-20 Terumo Corp Medical container
JP2007029368A (en) * 2005-07-26 2007-02-08 Otsuka Pharmaceut Factory Inc Medicine discharge appliance, medical dual chamber container having the same, and its manufacturing method
WO2007041408A2 (en) * 2005-09-29 2007-04-12 Alcon, Inc. Dual-chamber solution packaging system
JP2007267869A (en) * 2006-03-30 2007-10-18 Terumo Corp Medical vessel
JP2007307414A (en) * 2002-02-14 2007-11-29 Otsuka Pharmaceut Factory Inc Discharge method of medical agent
WO2008136452A1 (en) * 2007-04-27 2008-11-13 Ajinomoto Co., Inc. Double-cell container
WO2008149882A1 (en) * 2007-06-05 2008-12-11 Ajinomoto Co., Inc. Multichamber container
JP2009018038A (en) * 2007-07-12 2009-01-29 Ajinomoto Co Inc Multi-chambered container

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007307414A (en) * 2002-02-14 2007-11-29 Otsuka Pharmaceut Factory Inc Discharge method of medical agent
JP2005059853A (en) * 2003-08-11 2005-03-10 Shimizu Pharmaceutical Co Ltd Plastic container
JP2006187558A (en) * 2005-01-07 2006-07-20 Terumo Corp Medical container
JP2007029368A (en) * 2005-07-26 2007-02-08 Otsuka Pharmaceut Factory Inc Medicine discharge appliance, medical dual chamber container having the same, and its manufacturing method
WO2007041408A2 (en) * 2005-09-29 2007-04-12 Alcon, Inc. Dual-chamber solution packaging system
JP2007267869A (en) * 2006-03-30 2007-10-18 Terumo Corp Medical vessel
WO2008136452A1 (en) * 2007-04-27 2008-11-13 Ajinomoto Co., Inc. Double-cell container
WO2008149882A1 (en) * 2007-06-05 2008-12-11 Ajinomoto Co., Inc. Multichamber container
JP2009018038A (en) * 2007-07-12 2009-01-29 Ajinomoto Co Inc Multi-chambered container

Also Published As

Publication number Publication date
JP5728806B2 (en) 2015-06-03

Similar Documents

Publication Publication Date Title
TWI608838B (en) Multi-cell container
EP1750645B1 (en) Medical liquid container
JP5088604B2 (en) Drug storage sealing body
TWI401076B (en) Method for reinforcing weak sealed portion of multi-chamber medical container
JP5299640B2 (en) Multi-chamber container
JP5056754B2 (en) container
WO2008056605A1 (en) Multichamber container
JP2014023772A (en) Dual-chamber container
JP2006175212A (en) Medical liquid container and preparation-containing medical liquid container
JP2020179242A (en) Medical bag
JP5728806B2 (en) Medical multi-chamber container
JP5078385B2 (en) Medical container
JP5512586B2 (en) Medical multi-chamber container
JP2007260252A (en) Medical container
JP5491814B2 (en) Multi-chamber container
JP5053620B2 (en) Reinforcing method for weak seals in medical multi-chamber containers
JP2004305722A (en) Medicine bag
JP2009160266A (en) Medical multi-chamber container
JP2016131577A (en) Medical multi-chamber container
JP2006247378A (en) Medical dual chamber container
JP5078370B2 (en) Medical container
JP4609791B2 (en) Multi-chamber container
JP2005034637A (en) Filling and exhausting opening with displacement stopper and medical container with filling and exhausting opening with displacement stopper
JP4928799B2 (en) Medical multi-chamber container
JP2015054203A (en) Medical double-chamber container

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20121218

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20131025

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20131203

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140203

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140812

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141009

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150310

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150323

R150 Certificate of patent or registration of utility model

Ref document number: 5728806

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250